-
Intensity Therapeutics Finalizes Terms For $10 Million IPO
22 Sep 2022 15:16 GMT
… Landos Biopharma Seres Therapeutics BioAtla Epizyme Nanobiotix C4 Therapeutics Others Intensity … Therapeutics' IPO Date & Details The initial public offering, or IPO, for Intensity is … stocks with more history, IPOs typically have less information for …
-
The Week Ahead in Biotech (Nov. 7–Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs, and More
10 Nov 2021 13:45 GMT
… (before the market open)
Epizyme, Inc. (before the market … (before the market open)
IPOs
IPO Pricing
Dallas, Texas-based … A common stock in an initial public offering, The offering is expected … the ticker symbol “VAXX.”
IPO Quiet Period Expiry
Bone …
-
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
08 Nov 2021 13:38 GMT
… HAE) (before the market open)
Epizyme, Inc. (NASDAQ: EPZM) (before … (before the market open)
IPOs
IPO Pricing
Dallas, Texas-based Vaxxinity … common stock in an initial public offering, The offering is expected … "VAXX."
IPO Quiet Period Expiry
Bone …
-
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
04 Nov 2021 12:37 GMT
… Kidney Conference, More IPOs In The Pipeline
Chimerix … in premarket trading.
Epizyme's Blood Cancer … Gets Fast Track Designation
Epizyme, Inc. (NASDAQ: EPZM … IPOs
Hamburg, Germany-based Evotec SE (NASDAQ: EVO) priced its downsized initial public offering …
-
The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO
16 Jun 2021 13:22 GMT
… review issues at this time.
Epizyme, Quest Launch Follicular Lymphoma Diagnostic … Test
Epizyme, Inc. (NASDAQ: EPZM) announced the … : CNTG)
IPO
Swiss biopharma Molecular Partners AG priced its initial public offering of 3 …
-
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
07 May 2021 11:52 GMT
… Pharmaceuticals, Inc. (NASDAQ: ELOX)
Epizyme, Inc. (NASDAQ: EPZM) (announced … (before the market open)
IPOs
Talaris Therapeutics, Inc., a … therapy company priced its initial public offering of 8.825 million … addiction, priced its IPO of 3 million shares …
-
The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs
22 Apr 2021 12:24 GMT
…
Evofem Biosciences, Inc. (NASDAQ: EVFM)
Epizyme, Inc. (NASDAQ: EPZM)
Finch Therapeutics … close)
IPOs
Mountainview, California-based Neuropace Inc. priced its upsized initial public offering of … products, priced its upsized IPO of 16.13 million shares …